<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04484168</url>
  </required_header>
  <id_info>
    <org_study_id>CA2416</org_study_id>
    <nct_id>NCT04484168</nct_id>
  </id_info>
  <brief_title>Axial Ablation Versus Terminal Interruption of the Reflux Source</brief_title>
  <acronym>AAVTIRS</acronym>
  <official_title>Axial Ablation Versus Terminal Interruption of the Reflux Source (AAVTIRS): A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Hospital Galway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stewart R Walsh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wael Tawfick</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thomas A Aherne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mark Twyford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Marie O'Shaughnessy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Hospital Galway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomised trial aims to compare the effect on ulcer healing of different means of
      managing venous reflux in the lower limb. It is a non-inferiority trial comparing endovenous
      ablation of the axial (Saphenous and other large veins) veins of the lowere limb, versus
      terminal interruption of the reflux source (TIRS). For the purposes of this trial TIRS will
      be achieved using foam sclerotherapy of the distal tributaries in the immediate vicinity of
      the ulcer being treated.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 21, 2020</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ulcer healing</measure>
    <time_frame>6 months</time_frame>
    <description>The main outcome measure is the proportion of ulcers which have healed within the follow up period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ulcer Healing</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of ulcers healed at three months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in ulcer size</measure>
    <time_frame>6 months</time_frame>
    <description>The absolute reduction in ulcer size in square cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative Reduction in ulcer size</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction in ulcer size as a percentage of original ulcer area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Progress</measure>
    <time_frame>6 months</time_frame>
    <description>Progress in Wound regeneration as indicated by changes in Bates-Jensen Wound Assessment Tool (BWAT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in overall venous disease</measure>
    <time_frame>6 months</time_frame>
    <description>Monthly change in Venous Clinical Severity Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Venous disease related quality of Live</measure>
    <time_frame>6 months</time_frame>
    <description>Changes in Charing Cross Venous Ulcer Quesionnaire score from randomisation to exit from the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">308</enrollment>
  <condition>Venous Ulcer</condition>
  <arm_group>
    <arm_group_label>Terminal Interruption of the Reflux Source (TIRS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients will have foam sclerotherapy of the veins in the immediate vicinity of their venous ulcer and thereafter be managed in compression bandaging and followed up fro 6 months or until the ulcer has healed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Axial Ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients will undergo endovenous ablation of the great or small saphenous veins, or other large superficial veins exhibiting significant reflux</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Terminal Interruption of the Reflux Source</intervention_name>
    <description>Foam Sclerotherapy of veins in the immediate vicinity of the venous ulcer</description>
    <arm_group_label>Terminal Interruption of the Reflux Source (TIRS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Axial Ablation</intervention_name>
    <description>Endovenous ablation of venous reflux in the main superficial veins of the leg</description>
    <arm_group_label>Axial Ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Primary or recurrent venous leg ulcer

        Long or short saphenous vein reflux confirmed on ultrasound assessment, defined as
        retrograde flow lasting for &gt;0.5 seconds

        Ankle-Brachial pressure Index (ABI) ≥ 0.8 (if ulceration prevents ABI Toe-Brachial
        Index(TBI) ≥ 0.5 acceptable), or a palpable pulse

        Ulcer size between 1 and 200 cm2

        Patient suitable for full compression bandaging

        Exclusion criteria Pregnancy (or breastfeeding and needing to feed within 48 hours of
        treatment)

        Active infection of ulcer, or infection within the last two weeks

        Leg ulcer of non-venous aetiology as determined by clinical assessment

        Isolated perforator vein reflux only

        Evidence of deep venous insufficiency or thrombosis

        Known hypersensitivity to Sotradecol or similar sclerosants

        Previous inability to tolerate compression bandages

        Presence of any contraindications for the use of compression bandages:

        Absence of a palpable pulse, and Ankle Brachial Index (ABI) &lt;0.8

        Decompensated congestive cardiac failure (NYHA Class IV)

        Known hypersensitivity to any of the component materials

        Patients unable to provide informed consent

        Patients attending the leg ulcer clinic already will be excluded from enrolment with the
        same ulcer but will be eligible to enrol with a contralateral ulcer. Recurrent ipsilateral
        ulcers will not be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colum R Keohane, MB,BCh,BAO</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCH Galway and NUI Galway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colum R Keohane, MB,BCh,BAO</last_name>
    <phone>00353876492372</phone>
    <email>columkeohane@rcsi.ie</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stewart R Walsh, MCh,MD</last_name>
    <phone>0035391893642</phone>
    <email>stewartredmond.walsh@nuigalway.ie</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Roscommon Unversity Hospiral</name>
      <address>
        <city>Roscommon</city>
        <country>Ireland</country>
      </address>
    </facility>
    <contact>
      <last_name>Colum R Keohane, MB BCh BAO</last_name>
      <phone>00353876492372</phone>
      <email>columkeohane@rcsi.ie</email>
    </contact>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 20, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Hospital Galway</investigator_affiliation>
    <investigator_full_name>Colum Keohane</investigator_full_name>
    <investigator_title>Specialist Registrar in Vascular Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

